Compare LCTX & SRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LCTX | SRTA |
|---|---|---|
| Founded | 1990 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 407.7M | 472.4M |
| IPO Year | 1996 | N/A |
| Metric | LCTX | SRTA |
|---|---|---|
| Price | $1.49 | $4.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $5.33 | ★ $7.81 |
| AVG Volume (30 Days) | ★ 1.2M | 755.1K |
| Earning Date | 03-05-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,556,000.00 | N/A |
| Revenue This Year | $55.75 | $39.67 |
| Revenue Next Year | $2.96 | $8.84 |
| P/E Ratio | ★ N/A | $9.88 |
| Revenue Growth | ★ 53.24 | N/A |
| 52 Week Low | $0.37 | $3.85 |
| 52 Week High | $2.09 | $6.02 |
| Indicator | LCTX | SRTA |
|---|---|---|
| Relative Strength Index (RSI) | 37.77 | 38.75 |
| Support Level | $0.94 | $3.93 |
| Resistance Level | $1.84 | $5.46 |
| Average True Range (ATR) | 0.09 | 0.20 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 15.91 | 8.89 |
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. Its core services include air and ground logistics, surgical organ recovery, organ placement, and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.